969 related articles for article (PubMed ID: 14530746)
1. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock.
Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH
Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746
[TBL] [Abstract][Full Text] [Related]
2. Renal cell therapy in the treatment of patients with acute and chronic renal failure.
Humes HD; Weitzel WF; Fissell WH
Blood Purif; 2004; 22(1):60-72. PubMed ID: 14732813
[TBL] [Abstract][Full Text] [Related]
3. Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals.
Fissell WH; Lou L; Abrishami S; Buffington DA; Humes HD
J Am Soc Nephrol; 2003 Feb; 14(2):454-61. PubMed ID: 12538747
[TBL] [Abstract][Full Text] [Related]
4. Effect of continuous bioartificial kidney therapy on porcine multiple organ dysfunction syndrome with acute renal failure.
Huijuan M; Xiaoyun W; Xumin Y; Hengjin W; Xia S
ASAIO J; 2007; 53(3):329-34. PubMed ID: 17515724
[TBL] [Abstract][Full Text] [Related]
5. Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model.
Villar J; Ribeiro SP; Mullen JB; Kuliszewski M; Post M; Slutsky AS
Crit Care Med; 1994 Jun; 22(6):914-21. PubMed ID: 8205824
[TBL] [Abstract][Full Text] [Related]
6. Replacement of renal function in uremic animals with a tissue-engineered kidney.
Humes HD; Buffington DA; MacKay SM; Funke AJ; Weitzel WF
Nat Biotechnol; 1999 May; 17(5):451-5. PubMed ID: 10331803
[TBL] [Abstract][Full Text] [Related]
7. The future of renal support: high-flux dialysis to bioartificial kidneys.
Tiranathanagul K; Eiam-Ong S; Humes HD
Crit Care Clin; 2005 Apr; 21(2):379-94. PubMed ID: 15781170
[TBL] [Abstract][Full Text] [Related]
8. Continuous hemofiltration in pigs with hyperdynamic septic shock affects cardiac repolarization.
Stengl M; Sykora R; Krouzecky A; Chvojka J; Novak I; Varnerova V; Kuncova J; Nalos L; Sviglerova J; Matejovic M
Crit Care Med; 2008 Dec; 36(12):3198-204. PubMed ID: 18936693
[TBL] [Abstract][Full Text] [Related]
9. Bioartificial kidney in the treatment of acute renal failure associated with sepsis.
Tiranathanagul K; Brodie J; Humes HD
Nephrology (Carlton); 2006 Aug; 11(4):285-91. PubMed ID: 16889566
[TBL] [Abstract][Full Text] [Related]
10. [Application of tissue engineering in bioartificial renal tubule].
Zhang Y; Zhang J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jan; 19(1):144-7. PubMed ID: 11951504
[TBL] [Abstract][Full Text] [Related]
11. Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals.
Fissell WH; Dyke DB; Weitzel WF; Buffington DA; Westover AJ; MacKay SM; Gutierrez JM; Humes HD
Blood Purif; 2002; 20(1):55-60. PubMed ID: 11803160
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of hypertonic saline on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats.
Shih CC; Chen SJ; Chen A; Wu JY; Liaw WJ; Wu CC
Crit Care Med; 2008 Jun; 36(6):1864-72. PubMed ID: 18496380
[TBL] [Abstract][Full Text] [Related]
13. Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations.
Klouche K; Cavadore P; Portales P; Clot J; Canaud B; Béraud JJ
J Nephrol; 2002; 15(2):150-7. PubMed ID: 12018631
[TBL] [Abstract][Full Text] [Related]
14. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock.
Freeman BD; Yatsiv I; Natanson C; Solomon MA; Quezado ZM; Danner RL; Banks SM; Hoffman WD
J Am Coll Surg; 1995 Mar; 180(3):286-92. PubMed ID: 7874338
[TBL] [Abstract][Full Text] [Related]
15. The current management of septic shock.
Russel JA
Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
[TBL] [Abstract][Full Text] [Related]
16. [Induction mechanism of shock: applying the etiology in judgment of the cause of death in forensic practice].
Tanaka N
Nihon Hoigaku Zasshi; 2004 Sep; 58(2):130-40. PubMed ID: 15526767
[TBL] [Abstract][Full Text] [Related]
17. Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure.
Humes HD; Weitzel WF; Bartlett RH; Swaniker FC; Paganini EP
Blood Purif; 2003; 21(1):64-71. PubMed ID: 12566664
[TBL] [Abstract][Full Text] [Related]
18. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure.
Stegmayr BG; Banga R; Berggren L; Norda R; Rydvall A; Vikerfors T
Crit Care Med; 2003 Jun; 31(6):1730-6. PubMed ID: 12794412
[TBL] [Abstract][Full Text] [Related]
19. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
Sevransky JE; Shaked G; Novogrodsky A; Levitzki A; Gazit A; Hoffman A; Elin RJ; Quezado ZM; Freeman BD; Eichacker PQ; Danner RL; Banks SM; Bacher J; Thomas ML; Natanson C
J Clin Invest; 1997 Apr; 99(8):1966-73. PubMed ID: 9109441
[TBL] [Abstract][Full Text] [Related]
20. 15d-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria.
Dugo L; Collin M; Cuzzocrea S; Thiemermann C
Eur J Pharmacol; 2004 Sep; 498(1-3):295-301. PubMed ID: 15364008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
